Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Vida Ventures Advisors, LLC (CIK 1831423) reported $29.4M across 2 reported positions in its SEC 13F filing for 2025-09-30. Largest positions: KYTX ($27.1M, 92.41%), ALLO ($2.2M, 7.59%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | KYTX | KYVERNA THERAPEUTICS INC | $27.1M | 92.41% | 4.5M | Hold |
| 2 | ALLO | ALLOGENE THERAPEUTICS INC | $2.2M | 7.59% | 1.8M | Hold |
Source: SEC Form 13F filings · as of 2025-09-30